E C, Yang J, Li H, Li C. Cancer Manag Res. 2019;11:2871–2879
On page 2878, before Disclosure section, an Acknowledgment section should be placed to read
Acknowledgments
Changyong E and Jinghui Yang are co-first authors for this study.
. 2019 May 2;11:3971. doi: 10.2147/CMAR.S212734
LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling [Corrigendum]
Received 2019 Apr 18; Accepted 2019 Apr 18; Collection date 2019.
© 2019 E et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
PMCID: PMC6504669 PMID: 31118809
This corrects the article "LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling" on page 2871.